The Speed of Biological Engineering
Church, who co-founded Colossus and Dino Therapeutics, explains that the pace of biotech innovation has reached a critical inflection point. Where evolution required millions of base pair changes over vast timescales, modern gene editing tools now allow researchers to make billions of targeted modifications in mere hours.
This isn't theoretical speculation. Church points to real progress: researchers have successfully de-extincted a direwolf and are working on bringing back the woolly mammoth. The technology exists to create exact genetic copies of extinct species — and to generate hundreds of variations that could benefit ecosystems humans have damaged.
Escape Velocity for Aging
Perhaps the most startling claim Church makes involves aging itself. He believes we may reach "escape velocity" — a point where biotechnology advances faster than the aging process, extending life by at least one year for every year lived.
By 2050, Church predicts that people currently listening to this interview will have a reasonable chance of reaching that threshold. Rather than arriving at a future where everyone is desperately ill, he expects people will simply be healthier than they ever thought possible.
The hardest part isn't the science — it's the brain. While other organs can potentially be replaced through cellular therapy, the brain presents unique challenges. Church notes that even bringing in stem cells to learn neural circuits and displace old ones would require careful experiments still not completed.
Gene Therapy at Every Cell
When asked whether any existing gene delivery mechanism could reach every cell in the body, Church acknowledges nothing close to this exists today — but no physical law prevents it.
Church's own company, Dino Therapeutics, recently demonstrated a hundredfold improvement in targeting neurons. The experiment involved testing millions of different capsids (protein shells that deliver genetic material) using artificial intelligence. While current delivery requires multiple injections, Church believes achieving near-100% coverage across all tissues is within reach.
Some therapies only need 1% effectiveness to work — turning muscle cells into temporary immune system factories or producing brain enzymes in the liver if the goal is simply getting them through the bloodstream.
The Minimal Genome
Church is particularly interested in how few genetic changes can produce dramatic results. Height, for instance, involves roughly 10,000 genes — but extreme cases like dwarfism or gigantism can result from single mutations in growth hormone pathways. This reductionist approach has already produced seven different medical treatments.
The same principle applies to intelligence, health, and other complex traits. Church suggests we may discover that relatively few genetic "knobs" control high-level functions across all humans — meaning super-healthy individuals with Einstein-level intelligence might require only a handful of targeted edits rather than thousands of changes.
"What if we had 8 billion super healthy people? Don't need to worry about food and drugs. Super healthy, Einstein-level intelligence."
Bottom Line
Church's vision is genuinely ambitious: complete cellular replacement, reversal of aging, and species de-extinction all within reach using current technology. His biggest vulnerability is the unknown — there may be economic or complexity barriers we haven't anticipated that could halt progress. But given what's already been accomplished in just one afternoon of bioengineering, skeptics should consider what they've already seen.